Singapore markets close in 1 hour 39 minutes
Straits Times Index
3,257.81 -42.23 (-1.28%) Nikkei
38,202.37 -632.73 (-1.63%) Hang Seng
18,343.40 -135.97 (-0.74%) FTSE 100
8,344.18 +30.51 (+0.37%) Bitcoin USD
62,361.55 -1,196.75 (-1.88%) CMC Crypto 200
1,295.60 +0.93 (+0.07%)
AXSM Jan 2025 82.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 04:49PM EDT. Market open.
| Previous close | 12.07 |
| Open | 12.17 |
| Bid | 14.00 |
| Ask | 15.80 |
| Strike | 82.50 |
| Expiry date | 2025-01-17 |
| Day's range | 12.07 - 12.17 |
| Contract range | N/A |
| Volume | |
| Open interest | 14 |
ZacksAxsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Axsome's (AXSM) bottom line declines year over year in the first quarter. Strong sales of Auvelity drive revenues.
Insider MonkeyAxsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript May 6, 2024 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.44233 EPS, expectations were $-1.2. Axsome Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
- GuruFocus.com
Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
Discover how Axsome Therapeutics achieved a 160% revenue increase and navigated heightened R&D and operational costs in Q1 2024.
© 2024 Yahoo. All rights reserved.